Annual Drug Patent Expirations for BENDEKA
Bendeka is a drug marketed by Eagle Pharms and is included in one NDA. It is available from one supplier. There are sixteen patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for BENDEKA.
This drug has ninety-two patent family members in thirty-one countries.
The generic ingredient in BENDEKA is bendamustine hydrochloride. One supplier is listed for this compound. Additional details are available on the bendamustine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
